Skip to content
akaturk Academic measurement
Sign in Register

Journal catalog

Journals

Turkey-focused journal catalog — combines Scopus (Scimago/SJR) and Web of Science / JCR metrics by ISSN coverage. Read quartile, JIF, and index membership side by side.

WoS / JCR data covers 1997 onward.

66,811 Total journals
11,763 JCR matched
21,112 TR publication match
1,022,453 Matched publications

Results

Journal list

Scopus side is Scimago SJR; WoS side is Clarivate JCR. TR matches come from YÖKSİS article records linked by ISSN.

30 journals · 1,022,453 matched publications · Page 1 / 2

2025 SJR Q1 JCR Q3 · 2,3 SCIE

Genes Chromosomes and Cancer

Wiley-Liss Inc. · United States

  • Cancer Research Q2
  • Genetics Q1
  • 1,31 SJR
  • 137 H-Index
  • 2,73 Cites/doc
2025 SJR Q1 JCR Q3 · 3,4 OA ESCI

Cell Stress

Shared Science Publishers OG · Austria

  • Biochemistry, Genetics and Molecular Biology (miscellaneous) Q1
  • Cancer Research Q2
  • 1,198 SJR
  • 33 H-Index
  • 3 Cites/doc
2025 SJR Q1 JCR Q3 · 2,9 SCIE

Journal of Immunotherapy

Lippincott Williams and Wilkins · United States

  • Cancer Research Q2
  • Immunology Q2
  • 1,088 SJR
  • 111 H-Index
  • 2,75 Cites/doc
2025 SJR Q2 JCR Q3 · 2,4 SCIE

Current Opinion in Oncology

Lippincott Williams and Wilkins · United States

  • Cancer Research Q2
  • Oncology Q2
  • 0,979 SJR
  • 108 H-Index
  • 2,43 Cites/doc
2025 SJR Q2 JCR Q3 · 2,7 SCIE

Clinical Breast Cancer

Elsevier Inc. · United States

  • Cancer Research Q2
  • Oncology Q2
  • 0,932 SJR
  • 88 H-Index
  • 2,72 Cites/doc
2025 SJR Q2 JCR Q3 · 2,1 SCIE

Leukemia and Lymphoma

Taylor and Francis Ltd. · United Kingdom

  • Cancer Research Q3
  • Hematology Q2
  • 0,861 SJR
  • 109 H-Index
  • 1,64 Cites/doc
2025 SJR Q2 JCR Q3 · 2,8 SCIE

Human Cell

Springer · Japan

  • Cancer Research Q3
  • Cell Biology Q3
  • 0,854 SJR
  • 52 H-Index
  • 3,01 Cites/doc
2025 SJR Q2 JCR Q3 · 2,5 OA SCIE

Cancer Chemotherapy and Pharmacology

Springer Science and Business Media Deutschland GmbH · Germany

  • Cancer Research Q3
  • Oncology Q2
  • 0,851 SJR
  • 132 H-Index
  • 2,44 Cites/doc
2025 SJR Q2 JCR Q3 · 2,7 SCIE

Clinical and Translational Oncology

Springer Science and Business Media Deutschland GmbH · Germany

  • Cancer Research Q3
  • Medicine (miscellaneous) Q2
  • 0,833 SJR
  • 69 H-Index
  • 2,81 Cites/doc
2025 SJR Q2 JCR Q3 · 2,2 OA ESCI

Breast Cancer: Basic and Clinical Research

SAGE Publications Ltd · United Kingdom

  • Cancer Research Q3
  • Oncology Q2
  • 0,816 SJR
  • 40 H-Index
  • 2,1 Cites/doc
2025 SJR Q2 JCR Q3 · 2,6 OA ESCI

JMIR Cancer

JMIR Publications Inc. · Canada

  • Cancer Research Q3
  • Oncology Q2
  • 0,798 SJR
  • 31 H-Index
  • 3,12 Cites/doc
2025 SJR Q2 JCR Q3 · 2,4 OA ESCI

FASEB BioAdvances

John Wiley and Sons Inc · United Kingdom

  • Biochemistry, Genetics and Molecular Biology (miscellaneous) Q2
  • Cancer Research Q3
  • 0,776 SJR
  • 26 H-Index
  • 2,31 Cites/doc
2025 SJR Q2 JCR Q3 · 1,8 SCIE

Melanoma Research

Lippincott Williams and Wilkins · United States

  • Cancer Research Q3
  • Dermatology Q2
  • 0,74 SJR
  • 86 H-Index
  • 1,73 Cites/doc
2025 SJR Q2 JCR Q3 · 2,3 ESCI

World Journal of Oncology

Elmer Press · Canada

  • Cancer Research Q3
  • Oncology Q2
  • 0,735 SJR
  • 17 H-Index
  • 2,23 Cites/doc
2025 SJR Q2 JCR Q3 · 2,8 OA SCIE

Discover Oncology

Springer Science and Business Media B.V. · Netherlands

  • Cancer Research Q3
  • Endocrine and Autonomic Systems Q3
  • 0,731 SJR
  • 50 H-Index
  • 2,7 Cites/doc
2025 SJR Q2 JCR Q3 · 2,5 SCIE

Current Cancer Drug Targets

Bentham Science Publishers · United Arab Emirates

  • Cancer Research Q3
  • Drug Discovery Q2
  • 0,726 SJR
  • 109 H-Index
  • 2,95 Cites/doc
2025 SJR Q3 JCR Q3 · 2,5 OA ESCI

Cancer Reports

Wiley-Blackwell Publishing Ltd · United Kingdom

  • Cancer Research Q3
  • Oncology Q3
  • 0,707 SJR
  • 30 H-Index
  • 2,5 Cites/doc
2025 SJR Q2 JCR Q3 · 2,7 OA SCIE

Technology in Cancer Research and Treatment

SAGE Publications Inc. · United States

  • Cancer Research Q3
  • Medicine (miscellaneous) Q2
  • 0,674 SJR
  • 78 H-Index
  • 2,86 Cites/doc
2025 SJR Q2 JCR Q3 · 2,5 SCIE

Japanese Journal of Clinical Oncology

Oxford University Press · United Kingdom

  • Cancer Research Q3
  • Medicine (miscellaneous) Q2
  • 0,652 SJR
  • 102 H-Index
  • 2,2 Cites/doc
2025 SJR Q3 JCR Q3 · 2,1 SCIE

Oncology Letters

Spandidos Publications · Greece

  • Cancer Research Q3
  • Oncology Q3
  • 0,652 SJR
  • 97 H-Index
  • 2,12 Cites/doc
2025 SJR Q2 JCR Q3 · 2,4 SCIE

Recent Patents on Anti-Cancer Drug Discovery

Bentham Science Publishers · United Arab Emirates

  • Cancer Research Q3
  • Drug Discovery Q2
  • 0,635 SJR
  • 55 H-Index
  • 3,08 Cites/doc
2025 SJR Q3 JCR Q3 · 2,1 OA ESCI

Molecular and Cellular Oncology

Taylor and Francis Ltd. · United Kingdom

  • Cancer Research Q3
  • Molecular Medicine Q3
  • 0,62 SJR
  • 39 H-Index
  • 2 Cites/doc
2025 SJR Q2 JCR Q3 · 2,5 SCIE

Neoplasma

AEPress, s.r.o. · Slovakia

  • Cancer Research Q3
  • Medicine (miscellaneous) Q2
  • 0,586 SJR
  • 62 H-Index
  • 2,28 Cites/doc
2025 SJR Q2 JCR Q3 · 2,3 OA SCIE

International Journal of Biological Markers

Wichtig Publishing Srl · Italy

  • Cancer Research Q4
  • Clinical Biochemistry Q3
  • 0,559 SJR
  • 50 H-Index
  • 2,03 Cites/doc